Normalization in the Appearance of Severly Damaged Psoriatic Nails Using Soft x-rays. A Case Report by Jaka Radoš et al.
27
Normalization in the Appearance of Severly Damaged 
Psoriatic Nails Using Soft x-rays. A Case Report
Jaka Radoš, Ivan Dobrić, Aida Pašić, Jasna Lipozenčić, Danijela Ledić-Drvar, 
Gordana Štajminger1
University Department of Dermatology and Venereology, Zagreb University Hospital 
Center; Private Clinic for Internal Medicine “Dr. Gordana Štajminger”, Opatička 8, 
Zagreb, Croatia
Corresponding author
Jaka Radoš, MD, MS 
University Department of Dermatology 
and Venereology





Received: December 8, 2006
Accepted: January 20, 2007
SUMMARY The prevalence of nail psoriasis varies considerably 
among different studies, ranging from 10% to 55%. In psoriatic 
arthritis, its prevalence is as high as 85%. In spite of the high 
prevalence of the disease, considerable functional, psychical and 
cosmetic discomforts for the affected patients, and recent advances 
in the management of skin psoriasis, an efficacious and longlasting 
treatment for psoriatic nails remains elusive. A 51-year-old male 
patient with skin psoriasis and severe psoriatic lesions of all his 
finger nails and toe nails is presented. Some nail plates were up 
to 30 times thicker than normal. The patient received radiotherapy 
with soft x-rays in a total dose of 13.5 Gy administered in nine 
fractionated doses of 1.5 Gy (43 kV, 25 mA, 0.6 mm aluminum filter) 
at one-week and two-week intervals. Upon therapy completion, 
the appearance of nail plates gradually improved to normalize 
completely at 12 months of therapy. Almost three years of therapy 
completion, the patient is free from both disease relapse and 
radiotherapy sequels. Considering the high therapeutic efficacy and 
longlasting remission achieved, this type of radiotherapy should be 
used in the treatment of severe psoriatic nail lesions with massive 
nail plate thickening, to alleviate psychical and functional difficulties 
associated with the disease.
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INTRODUCTION
 Nail involvement is recorded in some 50% of 
psoriasis patients, both adults and children. Nail 
psoriasis may develop isolated, i.e. without cuta-
neous lesions. Nail lesions are also quite frequent-
ly associated with arthropatic psoriasis (1-3). Pso-
riatic nail lesions entail many functional, cosmetic 
and psychical difficulties (4-7). Therapeutic results 
in nail psoriasis are rather modest; the more so, 
dermatologists generally pay little attention to 
these lesions, and if they do treat nail psoriasis, 
it usually consists of topical or intralesional appli-
cation of corticosteroids, with little and short-lived, 
mostly rather poor improvement.
 The aim of this case report is to present our 
results in the management of severe psoriatic nail 
lesions that caused great functional, cosmetic and 
psychical difficulties to the patient.
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CASE REPORT
 A 51-year-old male, railroad worker, was admit-
ted in October 2003 for psoriasis that had first oc-
curred about a year before, whereas nail lesions 
developed 3 months after the disease onset. The 
nails showed rapid thickening and elongation, to 
eventually assume a hoof-like appearance. The 
patient was disturbed by the appearance of his 
nails, also being unable to perform fine movements 
with his fingers (taking food, buttoning, washing) 
and suffering pain on walking. The patient did not 
complain of arthralgia but had been treated for de-
pression. He had received usual local therapy for 
his psoriatic skin changes but not for nail lesions. 
There was no psoriasis or congenital pachyonych-
ia in his family history.
 On admission, squamous plaques on the ex-
tremities and scalp covered about 10% of the 
patient’s body. All finger nails (Fig. 1a) showed 
grayish-yellowish discoloration, were grossly 
thickened, hoof-like, crumbling, partially detached 
from the nail bed; the nail thickness, i.e. subungual 
hyperkeratosis, measured 16-18 mm across distal 
ends of the nails, at hyponychium (Fig. 1b). The 
distal end of the nail crossed the hyponychium by 
some 10 mm. All toe nails (Fig. 1c) showed similar 
features as finger nails, with subungual hyperker-
atosis thickness of 13-22 mm.
 All routine biochemistry findings were normal 
except for HLA typing, which yielded positive B13 
and DR7 loci. The diagnosis of skin psoriasis was 
histologically verified. Biopsy specimens were not 
obtained from the nail bed. Onychomycosis was 
ruled out by direct microscopy and culture analy-
sis. Association with psoriatic arthritis was exclud-
ed by laboratory testing and roentgenogram.
 Therapeutic approach
 Since only mild skin psoriasis was present, the 
patient was treated with phototherapy (UVB) in 
combination with topical corticosteroids and kera-
tolytics. Fractionated radiotherapy with soft x-rays 
was administered for psoriatic nail lesions. The 
patient received a total of 13.5 Gy over 12 weeks 
in nine fractionated doses of 1.5 Gy upon distal 
phalanx of each finger/toe, 7 times at one-week 
intervals, and the last two at two-week intervals. 
The irradiated area included the nail, nail matrix, 
and periungual region of 5 mm in width. A tube of 
30 mm in diameter was used for irradiated area 
restriction, while the rest of the finger/toe was pro-
tected by lead plates. Therapy was administered 
by use of a Siemens Dermopan 2 device, manu-
factured in 1978, properly maintained and calibrat-
ed to ensure precise radiation dosage. Instrument 
characteristics: voltage 43 kV, current 25 mA, 0.6 
mm aluminum filter, and focus to skin distance 
15 cm.
 Prior to treatment, an informed consent in writ-
ing was obtained from the patient. During radio-
Figure 1a. Grayish-yellowish discoloration, crum-
bling, grossly thickened and irregularly shaped fin-
ger nails before radiotherapy.
Figure 1b. Before radiotherapy, subungual hyper-
keratosis on the middle finger nail measured 18 
mm.
Figure 1c. Yellowish, onychogryphotic toe nails 
before radiotherapy.
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therapy, the patient did not complain of any un-
pleasant sensations or side effects. Upon comple-
tion of radiotherapy, however, deterioration of skin 
psoriasis on the dorsal aspect of the hands was 
observed.
 Monitoring of therapeutic efficacy and  
 evaluation of results
 Photos of the nails were taken before, imme-
diately after, and at 6 and 12 months of therapy 
completion. The thickness of subungual hyperker-
atosis was measured by a ruler and expressed in 
mm. Upon completion of soft x-ray therapy (Figs. 
2a and 2b), improvement was only recorded in the 
proximal third of the nails, with a discernible ap-
pearance of lunula unguis. At 6 months of ther-
apy completion, nail plates of all fingers showed 
normal appearance in the proximal half, while the 
healthy nail plate growth ranged from 8 to 10 mm 
measuring from eponychium. The thickness of 
subungual hyperkeratosis decreased from the ini-
tial 16-18 mm to 6 mm. Therapeutic effect was not 
as good on toe nails, yet showing a healthy nail 
growth of 3-5 mm in the proximal part. At 6 months 
of therapy completion (Fig. 3), residual hyperkera-
tosis was mechanically removed by scraping and 
use of keratolytics. The patient was advised not to 
cut nails to prevent possible trauma and to ensure 
objective measurement. At 12 months of therapy 
completion, the nail plates of some fingers/toes 
assumed nearly normal appearance (Fig. 4a), 
while some still showed oily drops and onycholy-
sis in the distal fifth of the nail (Fig. 4b). Almost 
three years of therapy completion the patient is 
free from relapse of nail psoriasis, his nails show 
normal thickness, however, discoloration and slow 
growth persisted in some nails.
DISCUSSION
 It is currently a widely accepted opinion that 
epidermal hyperproliferation and incomplete cel-
lular differentiation, both of them demonstrated 
in skin psoriasis, involve nail matrix and nail bed 
as well. Clinical appearance of nail psoriasis de-
pends on the site of the disease activity (1-3). The 
most common manifestations of nail psoriasis are 
foveolae (pitting), discoloration (oily drops), sub-
ungual hyperkeratosis, subungual hemorrhage 
(splinter hemorrhages), and onycholysis. Involve-
ment of the entire nail matrix results in crumbled, 
thickened and loose nails (2).
Figure 2a. Upon radiotherapy, the appearance 
of finger nail plates normalized in distal third, 
with marked deterioration of skin psoriasis on the 
dorsal aspect of the hands.
Figure 2b. Normalization in the appearance of 
finger nail plates in distal third upon radiotherapy 
– a detail.
Figure 3. Six months of radiotherapy, excess 
hyperkeratosis was mechanically removed; normal 
appearance in the distal half of finger nail plates.
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 The origin and morphogenesis of nail plate 
have not yet been fully elucidated, however, the 
major part of the nail plate definitely derives from 
the nail matrix epithelium. The relative contribution 
of the nail bed to the formation of nail plate is still 
a matter of debate. It is considered that in healthy 
individuals, the nail bed keratinocytes account for 
1/5 of the nail plate thickness (mass), whereas in 
psoriasis (nail psoriasis in particular) their contri-
bution may be much greater, even exceeding 1/4 
according to some authors (8).
 It is well known that there is no efficient therapy 
for psoriasis, including nail psoriasis. Each type of 
psoriasis therapy (local preparations, photothera-
py, any form of systemic therapy) has only a certain 
static effect on the disease. While systemic ther-
apy (retinoids, cytostatics, immunosuppressants) 
frequently produces satisfactory results with pro-
longed remissions, because of a number of side 
effects it is not recommended when the disease 
is confined to nails alone or when nail lesions are 
more pronounced than skin changes. Although 
rarely useful, topical corticosteroids may in some 
cases be used in therapy of nail lesions, however, 
their prolonged application or use under occlusion 
may lead to skin atrophy (9). Intralesional applica-
tion of corticosteroids (injections into the proximal 
end of the nail) has also been described (10), how-
ever, usually with only temporary improvement, 
while their application may frequently be associat-
ed with painful sensation, thus this mode of treat-
ment is not in common use. Systemic therapy with 
oral retinoids, which have been introduced for se-
vere forms of cutaneous psoriatic lesions, may fre-
quently have beneficial effect on nail lesions (11), 
however, as discussed above, this mode of treat-
ment is not used in case of primary nail lesions. 
Some authors report on the use methotrexate as 
the most efficacious therapy for severe psoriatic 
nail lesions (12), yet its prolonged application may 
lead to permanent nail dystrophy, which should be 
borne in mind. Recently, reports on the favorable 
effects of low dose cyclosporine have appeared 
in the literature (13-15). Phototherapy using topi-
cal or oral methoxalen and UVA, with or without 
retinoids, has been described as a potentially ef-
ficient therapy for nail psoriasis (16). Like some 
other authors (2), we believe that phototherapy 
is of low efficacy in this entity. Local therapy may 
include cytostatics, e.g., 5-fluorouracil, 1.0% solu-
tion, with or without a nail penetration-enhancing 
vehicle (17,18), cyclosporine (19), calcipotriol oint-
ment (20), tazarotene 0.1% gel (21) and anthralin 
(22), however, with modest and short-lived or as 
yet inadequately investigated effects.
 X-ray therapy for psoriasis is rarely used, i.e. 
only for refractory localized lesions. Nail psoriasis 
is one of the indications for x-ray therapy. Prior to 
psoriatic nail irradiation, nail thickness should be 
determined and x-ray transmission through normal 
and affected nail assessed (23). While grenz rays 
can be used for psoriatic nails of normal thickness, 
this type of x-rays has proved less efficiacious in 
thickened psoriatic nails (24). Fast electron thera-
py penetrating nail bed, thus exerting a temporary 
therapeutic effect, has also been reported (25). 
However, x-rays are preferred for the treatment 
of nail psoriasis. Favorable results were observed 
in as many as 50% of patients treated with three 
doses of 1-1.5 Gy at week intervals (23). Finner-
ty was the first to describe three patients treated 
with 6 to 8 doses of 0.5-0.75 Gy in a total dose of 
Figure 4a. At one year of radiotherapy, almost 
complete normalization and normal thickness of 
finger nail plates.
Figure 4b. Oily drops and onycholysis persisted 
in the distal fifth of finger nail plates.
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4-6 Gy, which led to complete remission of psori-
atic lesions of all nails in several months. In two 
of these three patients, gradual improvement oc-
curred within 14 months, and in one patient within 
only 4 months (26). Kouskousis et al. suggest the 
use of 1 Gy at week intervals up to a total dose 
of 4-5 Gy in cases where other therapies have 
failed (27). Mensing also recommends the use of 
radiotherapy, 4x1.5 Gy at 8- to 10-day intervals, 
for isolated nail psoriasis in adult patients (28). Yu 
and King report on definitive yet temporary effect 
of superficial radiotherapy in 3 fractionated doses 
of 1.5 Gy (90 kV, 5 mA, 1.00 mm aluminum filter) 
in three patients with nail psoriasis. The effect was 
observable at week 10 and 15 of therapy comple-
tion, with considerable reduction of nail thickness. 
The improvement was of transient nature because 
there was no statistically significant difference be-
tween the treated and untreated nails at week 20 
of therapy completion (29).
 Our patient underwent soft x-ray therapy with 
a lower penetration compared with other forms of 
x-ray therapy and superficial x-ray therapy. The 
depth of soft x-ray penetration at given device 
properties was 5 mm. It should be noted that we 
used a higher total dose and greater number of 
exposures than those reported from the studies 
mentioned above, which exceeded the dose of 3-
12 Gy per irradiation field recommended by Paniz-
zon (23). Using this dose, we achieved a gradual 
but constant effect, which resulted in near normal 
appearance of the nail plates. A decrease in the 
linear nail growth was observed. In contrast to our 
expectation and the fact that finger nails gener-
ally grow completely in 6 months, a “normal nail 
plate” failed to grow even at 12 months of therapy 
completion. We also admit that the retarded nail 
growth due to the antimitotic effect of radiotherapy 
may have been desirable for better onychocyte 
differentiation; modulation of the nail growth rate 
for therapeutic purpose has also been reported 
elsewhere (30). 
CONCLUSIONS
 Fractionated application of soft x-rays in a total 
dose of 13.5 Gy resulted in almost complete clini-
cal normalization in the appearance of all finger 
nails and toe nails in a patient with the most se-
vere form of nail psoriasis described to date. This 
therapeutic effect could also be considered as di-
rectly demonstrating the primary involvement of 
the nail matrix. 
 Because of the well known carcinogenic poten-
tial of even low-dose radiation (1-10 Gy) (31,32), 
the management of benign dermatoses by radio-
therapy has been on a steady decrease, even in 
conditions with indication for its application, such 
as severe and persistent forms of nail and scalp 
psoriasis (23). Upon thorough weighing the risk-
to-benefit ratio of this therapy and side effects of 
systemic therapy with methotrexate and cyclo-
sporin as alternative therapeutic options, among 
others, we found the favorable characteristics of 
radiotherapy to prevail. In this case, radiotherapy 
proved efficacious, leading to longterm remission. 
High therapeutic efficacy improved the patient’s 
work ability and substantially upgraded his quality 
of life. While advocating individual approach in ev-
ery patient, with due consideration of the disease 
severity and difficulties it causes to patients, we 
believe that radiotherapy has and should hold its 
place in the management of nail psoriasis in the 
elderly with severe psoriatic nail lesions and mas-
sive subungual hyperkeratoses. 
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